President's Health Care Reform Plan and Drug Development in the Biotechnology Industry.
Examines the implications of the Clinton Administration health care reform plan for the development of breakthrough drugs and the flow of capital into the biopharmaceutical industry.
| Corporate Authors: | , |
|---|---|
| Format: | eBook |
| Language: | English |
| Published: |
[Place of publication not identified] :
[publisher not identified],
1994.
|
| Series: | U.S. Congressional Research.
|
| Subjects: | |
| Online Access: | Connect to the full text of this electronic book |
| Summary: | Examines the implications of the Clinton Administration health care reform plan for the development of breakthrough drugs and the flow of capital into the biopharmaceutical industry. |
|---|---|
| Item Description: | Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource. |
| Physical Description: | 1 online resource. |